Clinical benefits and recovery of delayed-type hypersensitivity in patients with aids-related complex treated with IMREG-1 or placebo
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13 (7), 999-1004
- https://doi.org/10.1016/0192-0561(91)90053-a
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Inhibition of HIV progression by dithiocarbThe Lancet, 1990
- RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DITIOCARB SODIUM ('IMUTHIOL') IN HUMAN IMMUNODEFICIENCY VIRUS INFECTIONThe Lancet, 1988
- Immunomodulatory Components Present in IMREG-1, an Experimental Immunosupportive BiologicNature Biotechnology, 1988
- Immunomodulators in Clinical MedicineAnnals of Internal Medicine, 1987
- Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.The Journal of Immunology, 1984